Lexogen, a biotech company dedicated to advancing RNA research with innovative RNA-Seq products, is pleased to introduce solutions specifically optimized for transcriptomics from challenging FFPE samples. Transcriptome profiling of formalin-fixed paraffin-embedded (FFPE) samples, often referred to as “biobank” samples, provides invaluable information to researchers, especially those studying cancer, drug design and development. However, FFPE samples represent […]

Providing Researchers with Comprehensive Tools for Advanced Bioinformatics Data Analysis BOSTON — BioBam, a leading provider of bioinformatics solutions, is pleased to announce the launch of OmicsBox 3.2 at the BIO-IT World Expo in Boston. This release showcases BioBam’s latest advancements in computational biology and bioinformatics, with a special focus on Single Cell and Long-Read […]

Shimadzu Scientific Instruments, Inc. (SSI), a Shimadzu Group company in the United States, established an R&D Center to enhance its product development capabilities for analytical and measurement equipment. The opening ceremony was held on April 10. The R&D Center consists of three locations, with one laboratory located at SSI’s headquarters in Maryland, an East Coast […]

Madison, WI USA. — Promega and INOVIQ Ltd (ASX:IIQ) (INOVIQ) are collaborating to unlock the commercial potential of exosomes as a key biomarker in cancer research. This agreement will offer Promega customers world-class exosome solutions for manual, automated and high-throughput exosome isolation and nucleic acid extraction. The strategic Supply and Distribution Agreement will provide researchers […]

New addition to Monarch’s sustainable nucleic acid purification portfolio is designed for hands-free isolation of viral nucleic acid from saliva, respiratory swabs and wastewater utilizing a magnetic bead-based method that enables high-throughput automation and highly sensitive detection and/or sequencing of viruses. Ipswich, MA, USA — New England Biolabs (NEB®) announces the release of its Monarch Mag […]

SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has received approval of its divestment plan for GRAIL from the European Commission (EC). While this does not mean the method of divestment has been finalized, the company is pleased to reach an agreement with the EC […]

Melbourn, UK — SPT Labtech is pleased to announce the appointment of Rob Walton as Chief Executive Officer (CEO) as of May 1st, 2024, succeeding former CEO David Newble. Rob joins SPT Labtech from GE Healthcare, where he served as President & CEO for EMEA. Prior to that, he led the Asia Pacific region, based […]

CINCINNATI, OHIO – The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, has announced the launch of a comprehensive menu of glycerol-free NGS enzymes for use in all steps of a Next Generation Sequencing (“NGS”) workflow. With this latest release, Meridian establishes itself as […]

Mountain View, Calif. – DNAnexus, Inc., the provider of the Precision Health Data Cloud, today announced that it will collaborate with Oracle to advance precision health. This visionary endeavor is intended to drive scientific breakthroughs and improve patient outcomes globally by accelerating innovation in genomics and healthcare. This collaboration will: Focus on connecting Oracle’s and […]

HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Dr. Andrew Last, Executive Vice President and Chief Operating Officer, is planning to retire by early September of 2024. Dr. Last will remain part of Bio-Rad’s executive leadership team to ensure […]